# Oramed Pharmaceuticals Inc.: Form 8-K, filed Mar 18, 2024

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 17:15 ET
- Period: 2024-03-12
- Accession: 0001213900-24-023584
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/ea0201979-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390024023584/ea0201979-8k_oramed.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-023584. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
